THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Michael Cookson

Concepts (581)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
90
2024
160
13.070
Why?
Prostatic Neoplasms
84
2024
271
12.720
Why?
Cystectomy
76
2024
103
10.030
Why?
Prostatectomy
51
2020
83
7.070
Why?
Carcinoma, Transitional Cell
33
2023
55
4.290
Why?
Urology
12
2021
27
3.710
Why?
Prostatic Neoplasms, Castration-Resistant
8
2020
11
3.660
Why?
Male
196
2024
13034
2.990
Why?
Prostate-Specific Antigen
23
2024
51
2.690
Why?
Kidney Neoplasms
22
2020
100
2.680
Why?
Humans
238
2024
27175
2.520
Why?
Robotics
11
2020
42
2.500
Why?
Aged
132
2024
5232
2.450
Why?
Urinary Diversion
20
2018
26
2.360
Why?
Neoplasm Staging
48
2023
463
2.310
Why?
Neoplasm Recurrence, Local
28
2021
312
2.300
Why?
Androgen Antagonists
12
2020
17
2.190
Why?
Middle Aged
135
2024
6918
2.170
Why?
Prostate
16
2020
51
2.050
Why?
Nephrectomy
16
2017
47
1.940
Why?
Laparoscopy
13
2014
143
1.920
Why?
Postoperative Complications
25
2019
607
1.840
Why?
Blood Loss, Surgical
15
2013
52
1.650
Why?
Treatment Outcome
55
2024
2289
1.650
Why?
Neoadjuvant Therapy
14
2023
69
1.610
Why?
Neoplasm Invasiveness
35
2024
180
1.550
Why?
Medical Oncology
4
2021
87
1.550
Why?
Lymph Node Excision
15
2014
96
1.530
Why?
Aged, 80 and over
57
2024
1943
1.520
Why?
Carcinoma, Renal Cell
14
2017
77
1.520
Why?
Antineoplastic Agents
9
2021
659
1.440
Why?
Antineoplastic Combined Chemotherapy Protocols
8
2022
375
1.390
Why?
Prognosis
28
2020
762
1.380
Why?
Retrospective Studies
53
2023
2464
1.210
Why?
Quality of Life
9
2024
467
1.110
Why?
Patient Preference
2
2018
28
1.100
Why?
Practice Guidelines as Topic
7
2020
235
1.070
Why?
Urinary Reservoirs, Continent
9
2018
13
1.050
Why?
Female
87
2024
14658
0.990
Why?
Carcinoma
5
2014
72
0.930
Why?
Adult
65
2021
7510
0.920
Why?
Robotic Surgical Procedures
5
2019
43
0.910
Why?
Ablation Techniques
3
2020
12
0.910
Why?
Carcinoma in Situ
10
2024
44
0.900
Why?
Antineoplastic Agents, Hormonal
6
2020
27
0.870
Why?
Length of Stay
16
2014
219
0.840
Why?
Urologic Neoplasms
4
2017
13
0.830
Why?
Germ-Line Mutation
2
2020
31
0.830
Why?
Blood Transfusion
7
2013
73
0.820
Why?
Chemotherapy, Adjuvant
12
2020
110
0.820
Why?
Lymph Nodes
3
2012
98
0.820
Why?
Genetic Testing
2
2020
64
0.800
Why?
Salvage Therapy
5
2020
32
0.780
Why?
Societies, Medical
7
2021
89
0.760
Why?
United States
22
2020
2063
0.750
Why?
Disease Management
3
2018
86
0.750
Why?
Biopsy, Needle
11
2013
47
0.740
Why?
Survival Rate
22
2021
412
0.720
Why?
Urologic Surgical Procedures
3
2017
22
0.720
Why?
Androstenes
2
2020
3
0.710
Why?
Osteoporotic Fractures
1
2020
5
0.710
Why?
Evidence-Based Medicine
6
2021
141
0.710
Why?
Follow-Up Studies
29
2024
990
0.700
Why?
Urinary Bladder Diseases
3
2013
9
0.690
Why?
Osteoporosis
1
2020
63
0.680
Why?
Immunotherapy
4
2024
139
0.670
Why?
BCG Vaccine
6
2024
13
0.670
Why?
Prospective Studies
29
2021
1224
0.650
Why?
Nutritional Status
2
2018
75
0.650
Why?
Cohort Studies
18
2021
864
0.600
Why?
Urologic Diseases
1
2018
6
0.590
Why?
Algorithms
3
2018
422
0.590
Why?
Perioperative Care
2
2019
35
0.590
Why?
Clinical Decision-Making
1
2018
61
0.590
Why?
Neoplasm Grading
7
2020
104
0.580
Why?
Hospitals
3
2020
73
0.550
Why?
Disease Progression
10
2020
458
0.540
Why?
Clostridium Infections
1
2017
66
0.530
Why?
Drug Resistance, Neoplasm
4
2020
151
0.520
Why?
Testicular Neoplasms
3
2006
15
0.510
Why?
Survival Analysis
8
2016
279
0.510
Why?
Ultrasound, High-Intensity Focused, Transrectal
1
2015
4
0.490
Why?
Risk Factors
27
2020
2043
0.480
Why?
Time Factors
18
2020
1573
0.480
Why?
Body Mass Index
7
2011
385
0.470
Why?
Critical Pathways
4
2005
16
0.470
Why?
Patient Readmission
4
2014
103
0.470
Why?
Radiotherapy, Adjuvant
3
2020
60
0.460
Why?
Consensus
5
2022
69
0.460
Why?
Practice Patterns, Physicians'
3
2013
160
0.460
Why?
Neoplasms, Germ Cell and Embryonal
2
2005
15
0.450
Why?
Tumor Burden
4
2013
108
0.440
Why?
Vena Cava, Inferior
2
2011
16
0.440
Why?
Risk Assessment
10
2018
597
0.420
Why?
Biomarkers, Tumor
8
2018
377
0.420
Why?
Osteoradionecrosis
1
2013
1
0.420
Why?
Pubic Bone
1
2013
3
0.420
Why?
Combined Modality Therapy
8
2021
293
0.420
Why?
Disease-Free Survival
11
2018
225
0.410
Why?
Radiation Injuries
1
2013
51
0.410
Why?
Administration, Intravesical
8
2024
16
0.410
Why?
Fractures, Bone
1
2013
44
0.400
Why?
Multivariate Analysis
10
2017
298
0.400
Why?
Biopsy
4
2010
202
0.390
Why?
Early Detection of Cancer
5
2024
122
0.390
Why?
Dietary Supplements
3
2019
220
0.380
Why?
Vena Cava Filters
1
2011
11
0.380
Why?
Internship and Residency
3
2017
228
0.380
Why?
Equipment Failure
1
2011
31
0.380
Why?
Erythrocyte Transfusion
1
2011
15
0.380
Why?
Genetic Predisposition to Disease
3
2020
666
0.360
Why?
Neoplasms, Multiple Primary
2
2018
27
0.350
Why?
Neoplasms, Second Primary
3
2009
21
0.340
Why?
Urothelium
4
2015
35
0.340
Why?
Renal Insufficiency
1
2009
20
0.330
Why?
Kidney
3
2017
275
0.330
Why?
Adenocarcinoma
3
2020
287
0.330
Why?
Proportional Hazards Models
10
2020
217
0.320
Why?
Physicians
2
2012
80
0.320
Why?
Cystoscopy
4
2018
16
0.320
Why?
Prostatic Intraepithelial Neoplasia
4
2011
10
0.320
Why?
Sarcopenia
2
2019
42
0.310
Why?
Von Hippel-Lindau Tumor Suppressor Protein
1
2008
11
0.310
Why?
Health Planning Councils
1
2008
2
0.310
Why?
Patient Selection
7
2016
143
0.300
Why?
Cystitis
2
2013
11
0.300
Why?
Erectile Dysfunction
4
2007
13
0.300
Why?
Surveys and Questionnaires
7
2014
932
0.290
Why?
Gonadotropin-Releasing Hormone
3
2020
37
0.290
Why?
Bone Marrow Neoplasms
1
2007
2
0.280
Why?
Age Factors
10
2021
724
0.280
Why?
Incidence
11
2018
553
0.280
Why?
Research Report
2
2017
22
0.270
Why?
Bone Marrow
1
2007
76
0.270
Why?
Checklist
2
2017
21
0.270
Why?
Adjuvants, Immunologic
4
2024
63
0.270
Why?
Predictive Value of Tests
8
2014
472
0.260
Why?
Urinary Incontinence
3
2013
20
0.260
Why?
Natural Orifice Endoscopic Surgery
2
2016
8
0.260
Why?
Testosterone
2
2020
68
0.260
Why?
Thrombocytopenia
1
2007
112
0.250
Why?
Insurance, Health
2
2017
51
0.250
Why?
Quality Improvement
2
2017
113
0.250
Why?
Urethra
4
2016
33
0.250
Why?
Lymphatic Metastasis
5
2012
119
0.250
Why?
Prostatic Hyperplasia
4
2010
8
0.250
Why?
Ureteral Obstruction
2
2009
12
0.240
Why?
Kaplan-Meier Estimate
7
2015
189
0.240
Why?
Abdominal Neoplasms
1
2004
1
0.240
Why?
Pelvic Neoplasms
1
2004
8
0.230
Why?
Adenoviridae
2
2024
66
0.230
Why?
Carcinoid Tumor
1
2004
3
0.220
Why?
Hepatocyte Nuclear Factor 3-alpha
2
2015
2
0.220
Why?
Smartphone
1
2024
58
0.220
Why?
Mobile Applications
1
2024
58
0.220
Why?
Specimen Handling
3
2013
30
0.220
Why?
Ureteral Neoplasms
2
2020
5
0.210
Why?
Surgical Staplers
1
2003
2
0.210
Why?
Hemostasis, Surgical
1
2003
7
0.210
Why?
Randomized Controlled Trials as Topic
3
2024
365
0.210
Why?
Taxoids
2
2016
36
0.200
Why?
African Americans
3
2012
348
0.200
Why?
Sarcoma, Endometrial Stromal
1
2002
3
0.200
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2014
58
0.200
Why?
Clinical Trials as Topic
2
2018
206
0.200
Why?
Mitomycin
1
2002
19
0.200
Why?
Eosinophilia
1
2002
7
0.200
Why?
Urination
2
2012
13
0.200
Why?
Decision Making
2
2018
170
0.200
Why?
Patient Discharge
2
2014
96
0.190
Why?
Lymphoma, Follicular
1
2002
13
0.190
Why?
Antibiotics, Antineoplastic
1
2002
31
0.190
Why?
Lidocaine
1
2001
27
0.190
Why?
Lymphoma, B-Cell
1
2002
18
0.190
Why?
Genital Neoplasms, Female
1
2002
61
0.190
Why?
Anesthetics, Local
1
2001
12
0.190
Why?
Pelvis
3
2011
37
0.190
Why?
Aminolevulinic Acid
2
2014
14
0.190
Why?
Urinary Bladder
5
2014
117
0.190
Why?
Infertility, Male
2
2006
23
0.180
Why?
Delivery of Health Care, Integrated
1
2021
13
0.180
Why?
Models, Organizational
1
2021
18
0.180
Why?
Recurrence
3
2012
317
0.180
Why?
Malnutrition
2
2011
30
0.180
Why?
Cysts
2
2007
21
0.180
Why?
Muscle, Smooth
3
2014
40
0.180
Why?
Leuprolide
1
2020
5
0.170
Why?
Endometrial Neoplasms
1
2002
187
0.170
Why?
Pyrimidinones
1
2020
15
0.170
Why?
Phenylurea Compounds
1
2020
16
0.170
Why?
Genetic Vectors
1
2020
107
0.170
Why?
Chromosomes, Human, Pair 8
1
2020
14
0.170
Why?
Seminal Vesicles
1
2020
5
0.170
Why?
Gene Expression Regulation, Neoplastic
2
2014
445
0.170
Why?
Lysosomes
1
2020
55
0.170
Why?
Parkinson Disease
1
2020
38
0.170
Why?
Genetic Therapy
1
2020
116
0.170
Why?
Adolescent
9
2014
2996
0.160
Why?
Ureteral Diseases
1
1999
1
0.160
Why?
Kidney Pelvis
1
1999
5
0.160
Why?
Neoplasm Metastasis
1
2020
151
0.160
Why?
Lymphocytes
1
2019
83
0.160
Why?
Abiraterone Acetate
1
2018
1
0.160
Why?
Orchiectomy
2
2020
12
0.160
Why?
Minimally Invasive Surgical Procedures
2
2017
70
0.150
Why?
Population Dynamics
1
2018
29
0.150
Why?
Neutrophils
1
2019
179
0.150
Why?
Induction Chemotherapy
1
2018
6
0.150
Why?
Cisplatin
4
2022
175
0.150
Why?
Urinalysis
1
2018
11
0.150
Why?
Reproducibility of Results
6
2014
752
0.150
Why?
Intestines
2
2012
117
0.150
Why?
Perioperative Period
1
2018
7
0.150
Why?
Tomography, X-Ray Computed
3
2018
467
0.150
Why?
Sensitivity and Specificity
5
2009
510
0.150
Why?
Tobacco Smoking
1
2018
35
0.150
Why?
Androstane-3,17-diol
1
2017
9
0.150
Why?
Anabolic Agents
1
2017
12
0.150
Why?
Databases, Factual
5
2017
253
0.150
Why?
Urologists
1
2017
5
0.150
Why?
Aldo-Keto Reductase Family 1 Member C3
1
2017
21
0.150
Why?
Receptors, GABA-A
1
2017
18
0.150
Why?
Physicians, Primary Care
1
2017
9
0.150
Why?
Insurance Coverage
1
2017
33
0.140
Why?
Patient Reported Outcome Measures
1
2018
57
0.140
Why?
Pain, Postoperative
3
2007
60
0.140
Why?
Comorbidity
4
2014
249
0.140
Why?
Postoperative Care
3
2007
67
0.140
Why?
Urethral Neoplasms
2
2009
3
0.140
Why?
Mitochondria
1
2020
333
0.140
Why?
Remission Induction
1
2017
50
0.140
Why?
Glutathione Transferase
1
1997
30
0.140
Why?
Hematocrit
2
2010
26
0.140
Why?
Hydronephrosis
3
2020
11
0.140
Why?
Carcinoma, Squamous Cell
2
2012
156
0.140
Why?
Androstenols
1
2016
2
0.140
Why?
Phenylthiohydantoin
1
2016
3
0.140
Why?
Nitriles
1
2016
32
0.130
Why?
Drug Administration Schedule
3
2013
218
0.130
Why?
Microtubule-Associated Proteins
1
2017
49
0.130
Why?
Reoperation
1
2017
144
0.130
Why?
Benzamides
1
2016
33
0.130
Why?
Receptors, Androgen
2
2006
26
0.130
Why?
Logistic Models
5
2012
398
0.130
Why?
Quality of Health Care
2
2013
78
0.120
Why?
Radiopharmaceuticals
1
2016
69
0.120
Why?
Anastomosis, Surgical
4
2012
37
0.120
Why?
Research Design
3
2018
173
0.120
Why?
Organ Size
3
2011
84
0.120
Why?
Rectum
3
2001
50
0.120
Why?
Translations
1
2014
2
0.120
Why?
Cell Cycle Proteins
1
2017
185
0.120
Why?
Urinary Tract
1
2014
3
0.120
Why?
Immunohistochemistry
5
2015
455
0.120
Why?
Nuclear Proteins
1
2017
245
0.120
Why?
Semen
1
1995
27
0.120
Why?
RNA, Messenger
1
2017
647
0.120
Why?
Diagnosis, Differential
3
2007
368
0.120
Why?
Photosensitizing Agents
1
2014
33
0.110
Why?
Forecasting
1
2014
71
0.110
Why?
Octamer Transcription Factor-3
1
2014
2
0.110
Why?
Tennessee
6
2014
26
0.110
Why?
Antibodies
1
1995
124
0.110
Why?
Young Adult
4
2018
2636
0.110
Why?
Income
1
2014
38
0.110
Why?
Postoperative Period
2
2012
67
0.110
Why?
Child Health Services
1
2013
7
0.110
Why?
Carcinoma, Small Cell
1
2013
14
0.110
Why?
Cell Proliferation
2
2017
774
0.110
Why?
International Classification of Diseases
1
2013
32
0.110
Why?
Prevalence
3
2019
475
0.110
Why?
Biopsy, Large-Core Needle
1
2013
7
0.110
Why?
Pathology
1
2013
8
0.110
Why?
Interdisciplinary Communication
1
2013
19
0.110
Why?
Penis
1
1993
16
0.110
Why?
Pelvic Pain
1
2013
10
0.100
Why?
Hematuria
1
2013
10
0.100
Why?
Smoking Cessation
1
2018
399
0.100
Why?
Microsurgery
1
1993
45
0.100
Why?
Health Services Accessibility
1
2014
90
0.100
Why?
Psychometrics
3
2014
118
0.100
Why?
Osteomyelitis
1
2013
13
0.100
Why?
Neoplastic Cells, Circulating
3
2005
24
0.100
Why?
Population Surveillance
1
2013
85
0.100
Why?
Hospitals, High-Volume
1
2012
8
0.100
Why?
Pilot Projects
3
2024
398
0.100
Why?
ABO Blood-Group System
1
2012
7
0.100
Why?
Organ Sparing Treatments
1
2012
2
0.100
Why?
Glucocorticoids
1
2013
114
0.100
Why?
Epidemiologic Methods
2
2009
21
0.100
Why?
Urinary Tract Infections
1
2013
39
0.100
Why?
Healthcare Disparities
1
2013
90
0.100
Why?
Palliative Care
2
2011
79
0.100
Why?
Ovarian Neoplasms
1
2018
567
0.100
Why?
Antigens, Differentiation
1
2012
21
0.100
Why?
Chemoradiotherapy
1
2012
43
0.100
Why?
Emergency Service, Hospital
1
2013
119
0.100
Why?
Antibodies, Heterophile
1
2011
3
0.100
Why?
Case-Control Studies
4
2020
708
0.100
Why?
Incidental Findings
1
2011
14
0.100
Why?
Lymphocele
1
2011
2
0.090
Why?
Kidney Tubules, Collecting
1
2011
4
0.090
Why?
Lymphedema
1
2011
14
0.090
Why?
Dissection
1
2011
20
0.090
Why?
F2-Isoprostanes
1
2011
2
0.090
Why?
Muscle, Skeletal
1
2016
622
0.090
Why?
Vascular System Injuries
1
2011
13
0.090
Why?
Muscles
2
2022
70
0.090
Why?
Ileus
1
2011
7
0.090
Why?
Probability
2
2009
75
0.090
Why?
Intubation, Gastrointestinal
1
2011
11
0.090
Why?
Obesity
2
2007
651
0.090
Why?
Wounds and Injuries
1
2013
168
0.090
Why?
Single-Blind Method
2
2018
43
0.090
Why?
Elective Surgical Procedures
1
2011
70
0.090
Why?
Models, Statistical
1
2011
122
0.090
Why?
History, 20th Century
2
2021
83
0.090
Why?
Venous Thrombosis
1
2011
98
0.090
Why?
Flutamide
3
2006
6
0.090
Why?
Monitoring, Physiologic
2
2018
55
0.090
Why?
Pulmonary Embolism
1
2011
126
0.080
Why?
Telemedicine
2
2024
163
0.080
Why?
Congresses as Topic
1
2010
32
0.080
Why?
Prostatic Diseases
1
2009
3
0.080
Why?
Pain Measurement
2
2007
163
0.080
Why?
Health Facility Size
1
2009
3
0.080
Why?
Feasibility Studies
3
2006
191
0.080
Why?
Surgery Department, Hospital
1
2009
12
0.080
Why?
Administration, Oral
2
2020
166
0.080
Why?
Sutures
2
2013
15
0.080
Why?
Hospital Mortality
4
2012
147
0.080
Why?
Early Diagnosis
2
2007
32
0.080
Why?
Chromosomes, Human, Pair 3
1
2008
17
0.080
Why?
Hypoxia-Inducible Factor 1
1
2008
11
0.080
Why?
Genes, Tumor Suppressor
1
2008
37
0.080
Why?
Endoscopy
1
2009
53
0.080
Why?
Observation
1
2008
5
0.080
Why?
Chi-Square Distribution
4
2012
144
0.080
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2009
73
0.080
Why?
Radiotherapy, Conformal
1
2008
15
0.080
Why?
Odds Ratio
2
2014
231
0.070
Why?
Vinblastine
2
2020
5
0.070
Why?
Protein-Tyrosine Kinases
1
2008
96
0.070
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2008
54
0.070
Why?
Methotrexate
2
2020
31
0.070
Why?
Aspirin
1
2009
122
0.070
Why?
C-Peptide
1
2007
8
0.070
Why?
Urinary Bladder Neck Obstruction
1
2007
4
0.070
Why?
Urination Disorders
1
2007
9
0.070
Why?
Risk
3
2014
133
0.070
Why?
Urethral Stricture
1
2007
7
0.070
Why?
Doxorubicin
2
2020
74
0.070
Why?
Deoxycytidine
2
2020
63
0.070
Why?
Azasteroids
1
2007
1
0.070
Why?
Glycated Hemoglobin A
1
2007
64
0.070
Why?
Quality Indicators, Health Care
1
2007
48
0.070
Why?
Carbon Radioisotopes
1
2007
19
0.070
Why?
Leptin
1
2007
67
0.070
Why?
Preoperative Period
2
2021
15
0.070
Why?
Goserelin
2
1997
2
0.070
Why?
Academic Medical Centers
1
2007
73
0.070
Why?
Proctitis
1
2006
1
0.070
Why?
Treatment Failure
1
2007
68
0.070
Why?
Retroperitoneal Space
2
2007
9
0.070
Why?
Sperm Banks
1
2006
1
0.070
Why?
Body Size
1
2006
30
0.070
Why?
Intensive Care Units
2
2009
45
0.070
Why?
Palpation
2
1997
7
0.070
Why?
Oxidative Stress
1
2011
630
0.070
Why?
Diarrhea
1
2006
54
0.070
Why?
Haplotypes
2
2020
279
0.070
Why?
Body Height
1
2006
57
0.070
Why?
Oncogene Proteins
1
2006
21
0.070
Why?
Femoral Nerve
1
2006
2
0.070
Why?
Sex Factors
3
2020
451
0.070
Why?
Androgens
1
2006
47
0.070
Why?
Enzyme Inhibitors
1
2007
247
0.060
Why?
Laparoscopes
1
2005
3
0.060
Why?
Magnetic Resonance Imaging
2
2018
811
0.060
Why?
Renal Veins
1
2005
7
0.060
Why?
Thrombectomy
1
2005
26
0.060
Why?
Double-Blind Method
2
2007
405
0.060
Why?
Regression Analysis
2
2017
209
0.060
Why?
Surgical Stomas
1
2004
6
0.060
Why?
Ureter
1
2004
7
0.060
Why?
Epithelial Cells
1
2006
240
0.060
Why?
Ileum
1
2004
23
0.060
Why?
Penile Neoplasms
1
2004
12
0.060
Why?
Intestinal Diseases
1
2004
11
0.060
Why?
Intraoperative Period
1
2004
21
0.060
Why?
Sickness Impact Profile
1
2003
4
0.060
Why?
Ultrasonography
3
2000
229
0.060
Why?
Intracellular Signaling Peptides and Proteins
1
2006
280
0.050
Why?
Registries
2
2017
382
0.050
Why?
Signal Transduction
3
2017
1374
0.050
Why?
Health Surveys
1
2003
78
0.050
Why?
Anesthesia
1
2003
25
0.050
Why?
Preoperative Care
3
1997
76
0.050
Why?
Pelvic Exenteration
1
2002
2
0.050
Why?
Genitalia, Female
1
2002
5
0.050
Why?
Tumor Cells, Cultured
2
2017
310
0.050
Why?
Vagina
1
2002
42
0.050
Why?
Tumor Microenvironment
1
2024
159
0.050
Why?
Carboplatin
1
2022
107
0.050
Why?
Administration, Rectal
1
2001
5
0.050
Why?
Health Knowledge, Attitudes, Practice
1
2024
283
0.050
Why?
Hysterectomy
1
2002
85
0.050
Why?
Cost Control
1
2021
9
0.050
Why?
Value-Based Purchasing
1
2021
3
0.050
Why?
Constriction, Pathologic
2
2012
34
0.050
Why?
Nephroureterectomy
1
2020
1
0.040
Why?
Comparative Effectiveness Research
1
2020
12
0.040
Why?
History, 21st Century
1
2021
49
0.040
Why?
Health Status
1
2001
146
0.040
Why?
Paraparesis, Spastic
1
2000
1
0.040
Why?
Nomograms
1
2020
9
0.040
Why?
Multifactorial Inheritance
1
2020
13
0.040
Why?
Propensity Score
1
2020
54
0.040
Why?
Community Networks
1
2020
10
0.040
Why?
Injections, Subcutaneous
1
2020
58
0.040
Why?
Dopaminergic Neurons
1
2020
16
0.040
Why?
Protective Factors
1
2020
16
0.040
Why?
Heterozygote
1
2020
64
0.040
Why?
Adenosine Triphosphatases
1
2000
49
0.040
Why?
Linkage Disequilibrium
1
2020
108
0.040
Why?
Urologic Surgical Procedures, Male
2
2014
15
0.040
Why?
Genetic Loci
1
2020
78
0.040
Why?
Ureteroscopy
1
1999
5
0.040
Why?
Mutation
2
2020
823
0.040
Why?
Urography
1
1999
12
0.040
Why?
Transcription, Genetic
2
2014
400
0.040
Why?
Prophylactic Surgical Procedures
1
2018
7
0.040
Why?
Genome-Wide Association Study
1
2020
239
0.040
Why?
Narrow Band Imaging
1
2018
1
0.040
Why?
Ovariectomy
1
2018
53
0.040
Why?
Chronic Disease
1
1999
265
0.040
Why?
Watchful Waiting
1
2018
18
0.040
Why?
Random Allocation
1
2018
148
0.040
Why?
Gene Expression Profiling
1
2020
438
0.040
Why?
Delayed Diagnosis
1
2017
18
0.040
Why?
ErbB Receptors
1
2017
96
0.040
Why?
American Cancer Society
1
2017
4
0.030
Why?
Aurora Kinase A
1
2017
2
0.030
Why?
Child, Preschool
3
2013
1101
0.030
Why?
Antigens, Surface
1
1997
39
0.030
Why?
Counseling
2
2007
52
0.030
Why?
Epithelium
1
1997
39
0.030
Why?
Brachytherapy
2
2007
50
0.030
Why?
Antigens, Neoplasm
1
1997
50
0.030
Why?
Medicaid
1
2017
54
0.030
Why?
Cardiovascular Diseases
1
2020
357
0.030
Why?
Selection Bias
2
2010
13
0.030
Why?
Keratin-14
1
2015
1
0.030
Why?
DNA Methylation
1
2017
150
0.030
Why?
Tissue Array Analysis
1
2015
24
0.030
Why?
Linguistics
1
2014
4
0.030
Why?
Republic of Korea
1
2014
10
0.030
Why?
Sperm Motility
1
1995
14
0.030
Why?
Multimodal Imaging
1
2014
22
0.030
Why?
North America
1
2014
39
0.030
Why?
Molecular Targeted Therapy
1
2016
128
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2015
188
0.030
Why?
Europe
1
2014
97
0.030
Why?
Mice
2
2015
4472
0.030
Why?
Child
3
2013
2163
0.030
Why?
Embryonic Stem Cells
1
2014
8
0.030
Why?
Oklahoma
1
2017
977
0.030
Why?
Sex Characteristics
1
2015
163
0.030
Why?
Open Reading Frames
1
2014
38
0.030
Why?
Diethylstilbestrol
1
1994
2
0.030
Why?
Urodynamics
1
1994
5
0.030
Why?
Maryland
1
2013
7
0.030
Why?
New York
1
2013
17
0.030
Why?
Adrenalectomy
1
1994
13
0.030
Why?
Databases, Genetic
1
2014
47
0.030
Why?
Florida
1
2013
54
0.030
Why?
Mutation, Missense
1
2014
68
0.030
Why?
Quantitative Trait Loci
1
2014
57
0.030
Why?
Ligation
1
2013
40
0.030
Why?
Neural Tube Defects
1
1994
20
0.030
Why?
Transcriptome
1
2015
205
0.030
Why?
DNA Mutational Analysis
2
2006
92
0.030
Why?
Estrogens
1
1994
56
0.030
Why?
Databases, Bibliographic
1
2013
10
0.030
Why?
Cell Nucleus
1
2014
135
0.030
Why?
Veins
1
1993
19
0.030
Why?
Penile Erection
1
1993
3
0.030
Why?
Constriction
1
1993
14
0.030
Why?
Vacuum
1
1993
11
0.030
Why?
Alleles
1
2014
347
0.030
Why?
Equipment and Supplies
1
1993
10
0.030
Why?
Cell Transformation, Neoplastic
1
2014
114
0.030
Why?
Infant
2
2013
971
0.030
Why?
Quality Assurance, Health Care
1
2013
62
0.030
Why?
Genotype
1
2014
445
0.030
Why?
Peripheral Vascular Diseases
1
1993
64
0.030
Why?
Patient Care Team
1
2013
62
0.030
Why?
Genetic Variation
1
2014
229
0.030
Why?
Arteries
1
1993
65
0.030
Why?
Cell Differentiation
1
2015
398
0.030
Why?
SEER Program
1
2012
46
0.030
Why?
Sequence Analysis, DNA
1
2014
365
0.030
Why?
Patient Satisfaction
1
1993
90
0.020
Why?
Mice, Knockout
1
2015
793
0.020
Why?
Cadherins
1
2012
24
0.020
Why?
Mice, SCID
1
2012
59
0.020
Why?
Neoplasm Transplantation
1
2012
88
0.020
Why?
Medicare
1
2012
119
0.020
Why?
False Positive Reactions
1
2011
30
0.020
Why?
Spinal Cord
1
1994
204
0.020
Why?
Drug Implants
1
2011
14
0.020
Why?
Mass Screening
1
2013
149
0.020
Why?
Recovery of Function
1
2012
112
0.020
Why?
Pneumonia, Aspiration
1
2011
4
0.020
Why?
Gastrointestinal Motility
1
2011
30
0.020
Why?
Digital Rectal Examination
1
2010
3
0.020
Why?
Microtomy
1
2010
2
0.020
Why?
Serum Albumin
1
2011
35
0.020
Why?
Weight Loss
1
2011
72
0.020
Why?
Statistics, Nonparametric
1
2010
80
0.020
Why?
Animals
2
2015
10082
0.020
Why?
Disease Models, Animal
1
2015
1406
0.020
Why?
Databases as Topic
1
2009
21
0.020
Why?
Guideline Adherence
1
2010
91
0.020
Why?
Cross-Sectional Studies
1
2012
936
0.020
Why?
Demography
1
2009
91
0.020
Why?
Reference Values
1
2009
199
0.020
Why?
Rats
1
2012
1544
0.020
Why?
False Negative Reactions
2
1998
24
0.020
Why?
Radiography
1
2009
201
0.020
Why?
Urinary Catheterization
1
2007
15
0.020
Why?
Adiponectin
1
2007
29
0.020
Why?
Angiomyolipoma
1
2007
2
0.020
Why?
Radioisotope Teletherapy
1
2007
1
0.020
Why?
Awards and Prizes
1
2007
9
0.020
Why?
Adenoma, Oxyphilic
1
2007
5
0.020
Why?
Dutasteride
1
2007
1
0.020
Why?
Carcinoma, Papillary
1
2007
18
0.020
Why?
Biomarkers
1
2011
736
0.020
Why?
Accreditation
1
2007
33
0.020
Why?
Diabetes Complications
1
2007
66
0.020
Why?
Radiation-Sensitizing Agents
1
2007
32
0.020
Why?
Waist-Hip Ratio
1
2006
8
0.020
Why?
Southeastern United States
1
2006
3
0.020
Why?
Metabolic Syndrome
1
2007
78
0.020
Why?
Abdomen
1
2006
41
0.020
Why?
Global Health
1
2007
43
0.020
Why?
Protein Deglycase DJ-1
1
2006
2
0.020
Why?
Drug Stability
1
2006
23
0.020
Why?
Electrophoresis, Gel, Two-Dimensional
1
2006
38
0.020
Why?
Microscopy, Electron
1
2006
94
0.020
Why?
Radiotherapy Dosage
1
2006
102
0.020
Why?
Physician-Patient Relations
1
2007
110
0.020
Why?
Attitude to Health
1
2006
87
0.020
Why?
Ketorolac
1
2005
9
0.020
Why?
Clinical Competence
1
2007
216
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2006
324
0.020
Why?
Transfection
1
2006
313
0.020
Why?
Infusions, Intravenous
1
2005
99
0.020
Why?
Cause of Death
1
2005
66
0.020
Why?
Curriculum
1
2007
271
0.020
Why?
Early Ambulation
1
2004
3
0.010
Why?
Bandages
1
2004
9
0.010
Why?
Gene Expression
1
2006
407
0.010
Why?
Hospital Costs
1
2003
29
0.010
Why?
Intestinal Pseudo-Obstruction
1
2002
4
0.010
Why?
Cell Line, Tumor
1
2006
1271
0.010
Why?
Spastin
1
2000
1
0.010
Why?
Chromosomes, Human, Pair 2
1
2000
7
0.010
Why?
England
1
2000
35
0.010
Why?
Pedigree
1
2000
154
0.010
Why?
Genetic Linkage
1
2000
93
0.010
Why?
Phenotype
1
2000
667
0.010
Why?
Smoking
1
2002
466
0.010
Why?
Glutamate Carboxypeptidase II
1
1997
2
0.010
Why?
Drug Therapy, Combination
1
1997
205
0.010
Why?
Polymerase Chain Reaction
1
1997
262
0.010
Why?
Brain
1
2000
710
0.010
Why?
Compliance
1
1994
21
0.010
Why?
Pressure
1
1994
88
0.010
Why?
Infant, Newborn
1
1994
851
0.010
Why?
Cookson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (581)
Explore
_
Co-Authors (20)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES